Bosmann H B, Penney D P, Case K R, Averill K
Proc Natl Acad Sci U S A. 1980 Feb;77(2):1195-8. doi: 10.1073/pnas.77.2.1195.
Autoradiographic localization of [3H]flunitrazepam in nuclei of the rat cerebral cortex was further confirmed by biochemical analysis of specific nuclear binding. Highly purified rat cerebral cortex nuclei were shown to bind [3H]flunitrazepam specifically. The Kd(app) for nuclear binding was 28 nM for the nuclei compared with a Kd(app) of 1.1 nM for binding of [3H] flunitrazepam to synaptosomal membrane fractions of the same tissue. Inhibition of the nuclear binding with inosine and hypoxanthine was greater than inhibition of the synaptic membrane fractions. These results lead to to conclude that specific binding may occur at both the synaptic membrane and the nuclear levels and that different endogenous ligands may compete at each site for binding. Furthermore, the possibility exists for translocation and alteration of the bound ligand complex from membrane site to nuclear site.
通过对特异性核结合的生化分析,进一步证实了[3H]氟硝西泮在大鼠大脑皮质细胞核中的放射自显影定位。高度纯化的大鼠大脑皮质细胞核显示能特异性结合[3H]氟硝西泮。与同一组织突触体膜部分结合[3H]氟硝西泮的表观解离常数(Kd(app))为1.1 nM相比,细胞核结合的Kd(app)为28 nM。肌苷和次黄嘌呤对核结合的抑制作用大于对突触体膜部分的抑制作用。这些结果表明,特异性结合可能发生在突触膜和核水平,并且不同的内源性配体可能在每个位点竞争结合。此外,存在结合配体复合物从膜位点转运到核位点并发生改变的可能性。